Your session is about to expire
← Back to Search
Calanolide A for HIV
Study Summary
This trial will test the safety and effectiveness of calanolide A in HIV-infected adults who have not used anti-HIV drugs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I have had an AIDS-related infection or cancer in the past.I am currently being treated for active tuberculosis in my lungs.I have had a blood transfusion in the last 3 months.I haven't had radiation or chemotherapy in the last 16 days and don't plan to during the study.I haven't had a fever of 39°C or higher in the last 14 days.I cannot take medications orally.I have hepatitis, hemophilia, or another blood disorder.I am currently taking prescribed medications.I have taken anti-HIV drugs before.I have serious heart, stomach, liver, nerve, or kidney issues.I am 18 years old or older.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still capacity for additional participants in this research?
"The clinicaltrial.gov page reveals that this experiment, first published on April 1st 2000 and last modified June 23rd 2005, is no longer enrolling participants. However, there are presently 485 other trials in search of volunteers."
Can I join this medical experiment as a participant?
"This clinical trial seeks 16 patients infected with HIV who are 18 years of age or older. The primary criterion for enrolment is meeting the minimum legal age requirement of 18."
Has this treatment received authorization from the Food and Drug Administration?
"Due to the paucity of safety and efficacy data, this therapy receieved a score of 1 on our team's evaluation scale. This denotes that it is currently in Phase 1."
Does this clinical trial restrict participants to those over 70 years of age?
"The precondition for eligibility to this medical trial necessitates that participants be between 18 and 65 years old. For individuals younger than 18, there are 108 clinical trials available; conversely, 353 clinical trials are catered towards senior citizens aged over 65."
Are there multiple locales in the US running this experiment?
"Chicago Ctr for Clinical Research in Chicago, Illinois, Anderson Clinical Research in Pittsburgh, Pennsylvania, and Burnside Clinic in Columbia, South carolina are just some of the sites currently taking part. An additional 7 medical centres have also been enlisted to contribute participants."
Share this study with friends
Copy Link
Messenger